Xiaoke Liu

Chengdu University of Traditional Chinese Medicine

Also affiliated with Tsinghua University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC”.

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.04.026

N/A

0DataRank · unranked

194 citations

Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac +32 more

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Lung Cancer(2020)10.1016/j.lungcan.2020.08.023

N/A

0DataRank · unranked

20 citations

Lingzhi Hong, Monique B. Nilsson, Shawna M. Hubert, Shuhong Wu, Waree Rinsurongkawong +11 more

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Nature(2021)10.1038/s41586-021-03898-1

N/A

0DataRank · unranked

459 citations

Xiuning Le, R. S. K. Vijayan, J. Kevin Hicks, Simon Heeke, Yasir Y. Elamin +28 more